Prof Curdin Conrad: Clinical Trials

1 trial sponsored by Prof Curdin Conrad, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Prof Curdin Conrad: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TYK2 Inhibition in Paradoxical Psoriasis
Deucravacitinib - Psoriasis
Phase 2 / Phase 3TerminatedProf Curdin Conrad22024-06-202025-04-02

Conditions studied

Psoriasis (1)

Interventions

deucravacitinib (1)

Countries

Switzerland (1)

Top investigators

Curdin Conrad, Professor (1)